Synopsis:
A global leader in design-led manufacturing and ER&D, the company reported strong Q1FY26 growth, expanded its stakeholding, and plans significant investments in Tamil Nadu and Karnataka, enhancing ESDM capabilities, creating jobs, and strengthening India’s semiconductor and electronics ecosystem.
Stock News
Pharma stock jumps after receiving approval to raise ₹4,500 Cr via QIP
During Tuesday’s trading session, shares of a global biopharmaceutical company engaged in the manufacturing of biotechnology products and research services are in focus, after the company launched a Qualified Institutions Placement (QIP) to raise up to Rs. 4,500 crores.